Nektar Says Eli Lilly Botched Autoimmune Drug Trials
Nektar Therapeutics is accusing Eli Lilly of butchering and delaying clinical trials for a new autoimmune-disease drug the two companies agreed to develop together, claiming the pharma giant ruined the drug's...To view the full article, register now.
Already a subscriber? Click here to view full article